SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001803599-26-000136
Concentrix (CNXC) Financials, Dividends & Stock Info
Explore comprehensive financial data for Concentrix, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (571 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
CNXCIndustrials
Concentrix (CNXC) is a data processing & outsourced services company. The company reports annual revenue of $9.7B and net income of $316M. Its profit margin is 3.3%.
Concentrix Key Financials(TTM Est.)
Revenue (TTM)↑ 2.2%
$9.7B
Net Income (TTM)↓ 609.1%
$316.1M
Profit Margin
3.3%
Top 100% in sector
Return on Equity
7.3%
Top 100% in sector
Debt/Equity
1.10
Top 50% in sector
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Concentrix Financial Health ScoreFY2025
0/100
Weak financial health; requires careful evaluation
-11 pts YoYProfitability15Liquidity75Solvency40Growth50Cash Flow65Efficiency38
This Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data Highlights
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Concentrix Official SEC Updates
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Open SEC filing
SEC 8-K
SEC 8-K: Item 2.02, 9.01
Official SEC filing update. Items: 2.02, 9.01.
Item 2.02, 9.01Accession 0001803599-26-000133
SEC 8-K
SEC 8-K: Item 5.02
Official SEC filing update. Items: 5.02.
Item 5.02Accession 0001803599-26-000126
SEC 10-Q
SEC 10-Q
Official SEC filing update.
10-QAccession 0001803599-26-000122
SEC 8-K
SEC 8-K: Item 5.02, 5.07, 9.01
Official SEC filing update. Items: 5.02, 5.07, 9.01.
Item 5.02, 5.07, 9.01Accession 0001803599-26-000092
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
Concentrix Recent Events
Earnings Results
Leadership Change
Leadership Change
Shareholder Vote
Earnings Results
Source: SEC EDGAR 8-K Filings
5-Year Revenue & Net Income Trend
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
About Concentrix
Concentrix Corporation is an American business process outsourcing company headquartered in Newark, California. It was a subsidiary of SYNNEX Corporation since 2006 and went public as an independent company on December 1, 2020. In 2025, Concentrix made it to #426 on the Fortune 500 list.
- Industry
- Data Processing & Outsourced Services
Valuation
Valuation Data UnavailablePrice-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
Profitability
Thin MarginsROE7.3%
vs 23.5% sector median / 20.8% avg
▼
Generates $7.3 in profit for every $100 of shareholder equity. Higher than 0% in Industrials.
Profit Margin3.3%
vs 11.0% sector median / 11.2% avg
▼
Keeps 3 cents of every dollar in revenue as profit. Higher than 0% in Industrials.
Revenue (TTM)*$9.7B
6th consecutive year of revenue growth.
Net Income (TTM)*$316M
* Some quarterly data is missing. Values are calculated based on annual report figures.
Profit margin 71% below sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
Financial Health
Above-Average LeverageDebt/Equity1.10
vs 0.79 sector median / 0.95 avg
▼
Carries $1.10 in debt for every $1 of equity. Lower debt than 50% in Industrials. Debt has increased over the past 5 years.
Total Debt$4.8B
Debt-to-equity ratio of 1.10 is above 1.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend
Dividend Data UnavailableDividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Concentrix 7-Year Revenue, Profit & Cash Flow History
Revenue has grown at a 13.0% CAGR over the past 6 years.
Annual Financials
FY2025 - FY2019| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $9.8B(+2.2%) | $9.6B(+35.2%) | $7.1B(+12.5%) | $6.3B(+13.2%) | $5.6B(+18.4%) | $4.7B(+0.2%) | $4.7B |
| Net Income | $-1,278,924,000(-609.1%) | $251.2M(-20.0%) | $313.8M(-27.9%) | $435.0M(+7.3%) | $405.6M(+146.1%) | $164.8M(+40.7%) | $117.2M |
| Total Assets | $10.8B | $12.0B | $12.5B | $6.7B | $5.0B | $5.2B | - |
| Total Debt | $4.6B | $4.7B | $4.9B | $2.2B | $802.0M | $1.1B | - |
| Total Equity | $2.7B | $4.0B | $4.1B | $2.7B | $2.6B | $2.3B | $1.5B |
| Profit Margin | -13.0% | 2.6% | 4.4% | 6.9% | 7.3% | 3.5% | 2.5% |
| ROE | -46.6% | 6.2% | 7.6% | 16.1% | 15.5% | 7.2% | 8.0% |
| ROA | -11.9% | 2.1% | 2.5% | 6.5% | 8.0% | 3.2% | - |
Quarterly Financials
Last 8 quarters| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.4B | $2.4B | $2.4B | $2.4B | $2.4B | $1.6B |
| Net Income | $70.3M | $88.1M | $42.1M | $70.3M | $16.6M | $66.8M | $52.1M | $77.6M |
| Total Assets | $10.8B | $12.4B | $12.4B | $11.9B | $12.2B | $12.1B | $12.2B | $8.4B |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Insider Trading
Loading chart...
Loading transactions...
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
Concentrix Free Cash Flow & Dividend Coverage
Free Cash Flow
$572.5M
FY2025
FCF Margin
5.8%
FCF / Revenue
Operating Cash Flow
$807.0M
Cash from operations
FCF / Net Income
-0.45x
Below earnings
Generates approximately $2M in free cash flow per day.
Cash Flow History
FY2019 - FY2025| Metric | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating CF | $449.7M | $507.6M | $514.2M | $600.7M | $678.0M | $667.5M | $807.0M |
| CapEx | -$111.1M | -$171.3M | -$149.1M | -$140.0M | -$180.5M | -$238.8M | -$234.5M |
| Free Cash Flow | $338.6M | $336.3M | $365.1M | $460.7M | $497.5M | $428.7M | $572.5M |
| FCF Margin | 7.2% | 7.1% | 6.5% | 7.3% | 7.0% | 4.5% | 5.8% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Concentrix Risk Factors
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Industrials. This is not a Billiver risk assessment for CNXC.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Concentrix FAQ
What is Concentrix's annual revenue?
Concentrix (CNXC) reported $9.7 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Is Concentrix profitable?
Yes, Concentrix is profitable with a 3.3% net profit margin and $316 million in net income (TTM). All figures from SEC EDGAR 10-K filings.
Does Concentrix pay dividends?
No, Concentrix (CNXC) does not currently pay dividends to shareholders.
What is Concentrix's financial health score?
Concentrix has a financial health score of 45/100 (Grade: F), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
How many years of Concentrix financial data are available?
7 years of financial data are available for Concentrix from FY2019 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.